AMAG Pharmaceuticals Announces Pricing of $175 Million of 2.50% Convertible Senior Notes Due 2019

AMAG Pharmaceuticals Announces Pricing of $175 Million of 2.50% Convertible Senior Notes Due 2019

[GlobeNewswire] – WALTHAM, Mass. — AMAG Pharmaceuticals, Inc. today announced the pricing of $175 million aggregate principal amount of 2.50% Convertible Senior Notes due 2019 (the notes) in an underwritten … more

View todays social media effects on AMAG

View the latest stocks trending across Twitter. Click to view dashboard

See who AMAG is hiring next, click here to view

Share this post